₹ 226.93 Cr
2.35%
NIFTY Healthcare TRI.
INF00XX01BL5
5000.0
1000.0
500
Mr. Dhimant Shah, Mr. Rohan Korde, Mr. Rajesh Bhatia
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | -2.51 | 19.39 | - |
NIFTY Healthcare TRI | 1.01 | 21.27 | 16.28 |
Equity
Debt
Others
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
Company | Holdings (%) |
---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 10.6 |
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 8.38 |
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.96 |
MAX HEALTHCARE INSTITUTE LIMITED EQ | 5.89 |
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 4.53 |
SUVEN PHARMACEUTICALS LIMITED EQ | 4.31 |
FORTIS HEALTHCARE LIMITED. EQ | 3.8699999999999997 |
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 3.4299999999999997 |
ASTER DM HEALTHCARE LIMITED EQ | 3.3000000000000003 |
LUPIN LIMITED EQ NEW F.V. RS.2/- | 3.01 |
Sector | Holdings (%) |
---|---|
Healthcare | 89.62 |
Chemicals | 4.92 |
Financial Services | 1.24 |
Capital Goods | 1.05 |
Information Technology | 1.0 |